# Adding Dexmedetomidine to Mannitol to Attenuate the Increase of Intracranial Pressure

> **NCT07064720** · PHASE2,PHASE3 · COMPLETED · sponsor: **Cairo University** · enrollment: 60 (actual)

## Conditions studied

- Dexmedetomidine

## Interventions

- **DRUG:** Dexmedetomidine with Mannitol
- **DRUG:** Mannitol (20%)

## Key facts

- **NCT ID:** NCT07064720
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-12
- **Primary completion:** 2025-12-22
- **Final completion:** 2026-01-15
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07064720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07064720, "Adding Dexmedetomidine to Mannitol to Attenuate the Increase of Intracranial Pressure". Retrieved via AI Analytics 2026-07-14 from https://api.ai-analytics.org/clinical/NCT07064720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*